$IPRU news out! Closed at .077 yesterday, but hit .128.

New Post Public Reply Private Reply Replies (0) Message Board
BCNstocks
$IPRU news out! Closed at .077 yesterday, but hit .128. There has been a large amount of accumulation above .10 in the last few days!

Innovative Product Opportunities, Inc., Pursues Market Development Company as Acquisition Target

http://www.accesswire.com/viewarticle.aspx?id=420643

09/24/2014 [ACCESSWIRE]

Majority Partners in Talks

TORONTO, ON / ACCESSWIRE / September 24, 2014 / Innovative Product Opportunities, Inc., (OTC Pink: IPRU) (PINKSHEETS: IPRU), a research and product development firm, is excited to announce that our first acquisition target has been identified.

Nadav Elituv, CEO of Innovative Product Opportunities Inc. stated, "We are very excited for the possibility to acquire a majority control of the target company that specializes in market development and industry representation." Mr. Elituv continued, "Over the next few weeks some major milestones are taking place with the company and as they are achieved several of the majority partners have expressed an interest in joining forces with us to grow the business."

"Upon successful completion of these milestones the majority of the partners will begin further discussions on entering into a binding letter of intent to acquire a majority interest of the marketing company to be run under the IPRU banner," concluded Mr. Elituv.

About Innovative Product Opportunities, Inc.

Innovative Product Opportunities, Inc. http://www.ipoinc.net is research and product development firm meeting the ideas of show designers needs in light tracking. The company plans to identify, design, produce & bring to market new and innovative automated stage lighting products for select clients. For more information visit our website at http://www.ipoinc.net.

This press release contains forward-looking statements that involve a number of risks and uncertainties. Any statement not regarding a historical fact is a forward-looking statement. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, but are not limited to, the company's ability to finance its planned expansion efforts; the company's ability to raise funds on acceptable terms; the company's ability to successfully adapt its business model and such other risks disclosed from time to time in the company's reports filed with the securities and exchange commission including those on the company's annual report on form 10-K. The company does not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in management's expectations, except as required by law.

CONTACT:

Innovative Product Opportunities, Inc.
info@ipoinc.net

Investor Relations:
ir@ipoinc.net
347-789-7131 (New York)
http://www.ipoinc.net

SOURCE: Innovative Product Opportunities, Inc
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 304

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Sintilimab Poised for New Milestone in Melanoma Fight

Updated Category News Views 39

An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 421

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 212

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 0

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 264

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 264

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Dar Global Eyes Dubai for Strategic Real Estate Moves

Updated Category News Views 0

Tapping into Dubai's Real Estate Allure Every seasoned investor knows the real estate game ain't for the faint of heart, especially when you’re playing in a market as competitive as Dubai's. But here comes Dar Global Capital Partners (DGCP), throwing their hat into the ring with a fresh strategy centered around high-value real estate. Sure, they aren't new to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Dandy® Celery Innovates Back-to-School Snacking Options

Updated Category News Views 53

Dandy® Celery Offers Innovative Snacking for Back-to-School Dandy® Produce, a leading name in fresh celery, is here to support families as they navigate back-to-school routines. They provide a variety of quick and healthy meal and snack options. Their fresh-cut celery sticks are a perfect addition to school lunches, afterschool snacks, and even quick sides for busy...

Continue Reading
General Dynamics (GD): Navigating Aerospace Headwinds and Opportunities

Updated Category News Views 209

General Dynamics: Current Market Dynamics General Dynamics Corporation (NYSE: GD) is widely recognized for its pivotal role in the aerospace and defense sectors. The company has a strong reputation, particularly for producing Gulfstream jets, alongside its diverse range of military and marine systems. Despite its established position, General Dynamics has been...

Continue Reading
SunCar Technology Group Inc. Enters NASDAQ Golden Dragon Index

Updated Category News Views 74

SunCar Technology Group Inc. Achieves Milestone Inclusion SunCar Technology Group Inc. (NASDAQ: SDA), a prominent player in the cloud-based B2B automotive services and insurance sector, proudly announces its recent addition to the NASDAQ Golden Dragon China Index. This significant achievement illustrates the company's upward journey and strengthens its market positioning....

Continue Reading
Strategic Investment by BrainsWay to Enhance Mental Health Solutions

Updated Category News Views 165

BrainsWay's Expansion Plans and Strategic Investment This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home. Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. FDA, and if granted, it will set a precedent as the first FDA-cleared medical...

Continue Reading
Future Projections: Cosmetic Surgery Market Growth Insights

Updated Category News Views 97

The Expanding Cosmetic Surgery Market The cosmetic surgery market is anticipated to experience significant growth over the coming years, with projections indicating an increase from USD 56.98 billion in 2024 to approximately USD 83.34 billion by 2034. This impressive growth represents a compound annual growth rate (CAGR) of 3.84% from 2024 to 2034, driven by a variety of...

Continue Reading